Lowell B Anthony

4PUBLICATIONS

26CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Autonomic nervous systemGlycoconjugatesMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jul 28, 2026

Multi-center Phase 1 study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388).

|Feb 25, 2022

hPG80 (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors.

Aman Chauhan, Alexandre Prieur, Jill Kolesar

|Jun 07, 2021

Opportunities to Improve Symptom Control with Somatostatin Congeners in GEP-NETs: A Review of Key Issues.

Lowell B Anthony, Thomas M O'Dorisio

|Jun 02, 2021

PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine Tumors.

Zeta Chow, Jeremy Johnson, Aman Chauhan

Pageof 1

Frequent Collaborators

Jill Kolesar

Madison Sands

Thomas M O'Dorisio

Aman Chauhan

Heidi L Weiss

Charles Kunos

Rani Jayswal

Bhavana Konda

Heloisa P Soares

Daneng Li

Frequent Collaborators

Jill Kolesar

Madison Sands

Thomas M O'Dorisio

Aman Chauhan